Catalyst Wire Dossier Catalyst Wire Dossier

Wharton jelly-derived mesenchymal stem cells

Wharton jelly-derived mesenchymal stem cells · TC Erciyes University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Wharton jelly-derived mesenchymal stem cells, covering 2020-03-18 to 2020-03-18. Get the full timeline:

Most recent: Clinical Trial Update: WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS [Phase 2]

See pricing